News
KTRA
0.1488
-5.82%
-0.0092
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Aon plc shares fell 7.4% to $283.19 on Friday. The company reported worse-than-expected quarterly financial results. Biodexa Pharmaceuticals Plc shares jumped 73.3% after the company signed a deal with eRapa. Snap Inc. Shares jumped 23% in the mid-day session.
Benzinga · 9h ago
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. Rose sharply in today's pre-market trading. The company reported upbeat results for its first quarter. Tevogen Bio Holdings Inc. Shares gained 64.7% after falling over 43% on Thursday. Skechers U.S.A., Inc. And Snap Inc. Also rose in pre- market trading.
Benzinga · 15h ago
These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)
Annual Meeting of the American Society of Clinical Oncology will be held in Chicago. The oral presentations will cover a range of topics including targeted therapies and immunologic therapies for various types of cancer. The plenary session will feature presentations on esophageal cancer, melanoma and lung cancer.
Seeking Alpha · 1d ago
Kintara Therapeutics Eyes Merger Amidst Clinical Trial Buzz
TipRanks · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
VolitionRX (AMEX:VNRX) shares rose 33.6% to $0.8 during Tuesday's regular session. Palisade Bio (NASDAQ:PALI) stock increased by 29.81% during the session. Kintara Therapeutics and NKGen Biotech were among the losers.
Benzinga · 3d ago
Weekly Report: what happened at KTRA last week (0415-0419)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 34.7% to $27.44 during Friday's regular session. NKGen Biotech stock increased by 19.76% and Adlai Nortye stock moved upwards by 16.33%. Other losers include SeaStar Medical Holding and iSpecimen.
Benzinga · 04/19 16:31
Weekly Report: what happened at KTRA last week (0408-0412)?
Weekly Report · 04/15 10:22
Weekly Report: what happened at KTRA last week (0401-0405)?
Weekly Report · 04/08 10:25
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Byrna Technologies shares jumped 7.1% to $14.74 on Friday. The company reported better-than-expected first-quarter revenue and announced a CFO transition. MediaCo Holding Inc. Shares jumped 141.7% in today's mid-day session.
Benzinga · 04/05 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Candel Therapeutics (NASDAQ:CADL) stock increased by 27.6% to $8.17 during Friday's regular session. The company's market cap stands at $239.6 million. Galectin Therapeutic shares increased by 20.66% and Ocugen stock moved upwards by 17.88%. Candel Therapeutical is one of the top gainers in the sector.
Benzinga · 04/05 16:31
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRA
Former Attorney General of Louisiana Charles C. Foti, Jr. And the law firm of Kahn Swick & Foti are investigating the proposed merger of Kintara Therapeutics, Inc. And TuHura Biosciences. KSF is seeking to determine whether the merger is fair to shareholders.
Barchart · 04/05 12:31
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
MediaCo (NASDAQ:MDIA) stock is rocketing more than 80% after a financing deal. The biggest pre-market stock movers on Friday morning are a delisting update, clinical trial data and more. DigiAsia shares are soaring over 79% after securing $8 million in financing.
Investorplace · 04/05 11:34
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. The company issued strong preliminary first-quarter net sales guidance. TC Biopharm (Holdings) Plc shares climbed 130.1% in the mid-day session.
Benzinga · 04/04 17:21
12 Health Care Stocks Moving In Thursday's Intraday Session
Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. Macrogenics ( NASDAQ:MGNX) stock rose 32.55% during the session. Barinthus Biotherapeutics shares increased by 29.55%.
Benzinga · 04/04 16:31
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
NASDAQ · 04/04 14:38
Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings
The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% on Wednesday. U.S. Stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3%. Acuity Brands, Inc. Reported better-than-expected earnings for its second quarter. European shares closed higher today; Asian markets closed lower.
Benzinga · 04/03 18:30
BUZZ-U.S. STOCKS ON THE MOVE-Identiv, Levi Strauss, cannabis firms
Wall Street's main indexes advanced on Wednesday. Softer-than-expected services sector data offered relief to investors. Dow Jones Industrial Average was up 0.14% at 39,226.61. Top three S&P 500 percentage gainers: GE Aerospace, Caesars Entertainment, Ulta Beauty.
Reuters · 04/03 18:01
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. The company reportedly issued a weak outlook at the J.P. Morgan Retail Roundup investor conference. ARCA biopharma, Inc. Shares climbed 108% in the mid-day session.
Benzinga · 04/03 17:56
12 Health Care Stocks Moving In Wednesday's Intraday Session
ARCA biopharma (NASDAQ:ABIO) shares moved upwards by 84.8% to $3.16 during Wednesday's regular session. Vanda Pharma shares rose by 39.38% and Kintara Therapeutics stock rose by 71.81% in the same session. The company's Q4 earnings report came out yesterday.
Benzinga · 04/03 16:31
More
Webull provides a variety of real-time KTRA stock news. You can receive the latest news about Kintara Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About KTRA
Kintara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of new cancer therapies. It is focused on the development of novel cancer therapies for patients with unmet medical needs. Its two candidates include VAL-083 and REM-001. VAL-083 is a novel, validated, deoxyribonucleic acid (DNA)-targeting agent, for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme (GBM) and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer (NSCLC), and diffuse intrinsic pontine glioma (DIPG). REM-001 is a late-stage photodynamic therapy (PDT) for the treatment of cutaneous metastatic breast cancer (CMBC), basal cell carcinoma nevus syndrome (BCCNS), and access graft failure in hemodialysis patients. VAL-083 is being evaluated in all three GBM patient subtypes in the GBM AGILE Study: newly diagnosed methylated MGMT; newly diagnosed unmethylated MGMT, and recurrent.